Dmpk consulting support services
Ended Purchase Order Awarded Last action
- Contract number
- 75N95021P00605
- Awardee
-
Pearson Pharma Partners UEI TJN3M3UNJF15
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $61,600
Award facts
- Opportunity
-
- Drug Metabolism and Pharmacokinetics (DMPK) Consultant Support Services Solicitation · NIHNINDSCSS21000199 · Posted Aug 10, 2021
- Contract value 12% obligated
-
- $61,600.00 Current, with exercised options
- $532,500.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Labor Hours
- Place of performance
- Thousand Oaks, CA 91362, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $48,400 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $13,200 |
About this award
The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $532,500 purchase order to Pearson Pharma Partners of Thousand Oaks, California for Drug Metabolism and Pharmacokinetics (DMPK) Consulting Support Services. The contract is set aside for small businesses and will provide senior-level DMPK consultants to advise the Blueprint Neurotherapeutics Program and other NIH neuroscience initiatives on study design, data analysis, and project milestones through September 2024. Consultants will perform the majority of work remotely with occasional travel to NIH facilities in Bethesda, Maryland. The original solicitation sought proposals for DMPK guidance to support the Blueprint Neurotherapeutics Program's efforts to accelerate development of new treatments for neurological disorders.
Quick answers
Who was awarded contract 75N95021P00605?
75N95021P00605 was awarded to Pearson Pharma Partners by National Institute on Drug Abuse (National Institutes of Health) on September 23, 2021.
How much is contract 75N95021P00605 worth?
The government has obligated $61,600 on 75N95021P00605. Its potential value, with all options, is $532,500.
Which agency awarded contract 75N95021P00605?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95021P00605, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Was contract 75N95021P00605 competed?
The extent of competition for 75N95021P00605 was competed under sap. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award